Kylmäniemio M, Autio P, Oikarinen A
Department of Dermatology, University of Oulu, Finland.
Arch Dermatol Res. 1995;287(5):434-8. doi: 10.1007/BF00373424.
The expression of two matrix metalloproteases (MMPs), 72 kDa gelatinase (MMP-2) and 92 kDa gelatinase (MMP-9), was studied in suction blister fluids and serum using a zymographic method. Both of the enzymes were detectable in blister fluid and serum, but their expression varied. The MMP-2 levels in serum were only about half of the levels in blister fluid, while the level of MMP-9 was about the same in both serum and blister fluid. The overall level of MMP-2 in serum was much lower than the level of MMP-9 which was possibly derived from inflammatory cells. In subjects aged from 20 to 86 years, no marked changes were seen in the serum or blister fluid gelatinases. Interestingly, body site affected the level of MMP-9. The lowest level was recorded in fluid from blisters on the lower leg, in which the level was only about 19% of the level in fluid from blisters on the abdomen. The levels of MMP-2 and MMP-9 were not decreased by pharmacological doses of systemic prednisone or isotretinoin, which indicates that systemic glucocorticoid or retinoid treatment does not affect the basal levels of MMP-2 and MMP-9.
采用酶谱法研究了两种基质金属蛋白酶(MMPs),即72 kDa明胶酶(MMP-2)和92 kDa明胶酶(MMP-9)在抽吸水疱液和血清中的表达情况。在水疱液和血清中均能检测到这两种酶,但它们的表达有所不同。血清中MMP-2的水平仅约为水疱液中水平的一半,而MMP-9在血清和水疱液中的水平大致相同。血清中MMP-2的总体水平远低于可能来源于炎症细胞的MMP-9的水平。在20至86岁的受试者中,血清或水疱液中的明胶酶未见明显变化。有趣的是,身体部位会影响MMP-9的水平。小腿水疱液中的水平最低,仅约为腹部水疱液中水平的19%。药理剂量的全身性泼尼松或异维A酸并未降低MMP-2和MMP-9的水平,这表明全身性糖皮质激素或维甲酸治疗不会影响MMP-2和MMP-9的基础水平。